tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Shenzhen Hepalink Reports Decrease in Interim Financial Results for 2025
Company AnnouncementsShenzhen Hepalink Reports Decrease in Interim Financial Results for 2025
11d ago
9989
Shenzhen Hepalink to Review Interim Results and Consider Dividend
PremiumCompany Announcements
Shenzhen Hepalink to Review Interim Results and Consider Dividend
25d ago
9989
Shenzhen Hepalink Advances H1710 Injection to Phase I Clinical Trial
PremiumCompany Announcements
Shenzhen Hepalink Advances H1710 Injection to Phase I Clinical Trial
2M ago
9989
Shenzhen Hepalink Announces Final Dividend for 2024
PremiumCompany Announcements
Shenzhen Hepalink Announces Final Dividend for 2024
3M ago
9989
Shenzhen Hepalink Gains EMA Authorization for Enoxaparin Sodium Injection
PremiumCompany Announcements
Shenzhen Hepalink Gains EMA Authorization for Enoxaparin Sodium Injection
3M ago
9989
Shenzhen Hepalink Pharmaceutical Group Approves Key Resolutions at 2024 AGM
PremiumCompany AnnouncementsShenzhen Hepalink Pharmaceutical Group Approves Key Resolutions at 2024 AGM
4M ago
9989
Shenzhen Hepalink Updates Final Dividend Details for 2024
Premium
Company Announcements
Shenzhen Hepalink Updates Final Dividend Details for 2024
4M ago
9989
Shenzhen Hepalink Announces 2024 AGM and Key Resolutions
Premium
Company Announcements
Shenzhen Hepalink Announces 2024 AGM and Key Resolutions
4M ago
9989
Shenzhen Hepalink Releases 2025 Q1 Financial Report
PremiumCompany Announcements
Shenzhen Hepalink Releases 2025 Q1 Financial Report
5M ago
9989
Shenzhen Hepalink’s Ivenoxin Gains Approval for South African Market
PremiumCompany Announcements
Shenzhen Hepalink’s Ivenoxin Gains Approval for South African Market
5M ago
9989
Shenzhen Hepalink Schedules Board Meeting for Q1 Results
PremiumCompany Announcements
Shenzhen Hepalink Schedules Board Meeting for Q1 Results
5M ago
9989
Shenzhen Hepalink Announces Changes in Nomination Committee
PremiumCompany Announcements
Shenzhen Hepalink Announces Changes in Nomination Committee
5M ago
9989
Shenzhen Hepalink Announces Board of Directors and Committee Roles
PremiumCompany AnnouncementsShenzhen Hepalink Announces Board of Directors and Committee Roles
5M ago
9989
Shenzhen Hepalink Announces Final Dividend for 2024
Premium
Company Announcements
Shenzhen Hepalink Announces Final Dividend for 2024
5M ago
9989
Shenzhen Hepalink Reports Strong Profit Recovery in 2024 Annual Results
Premium
Company Announcements
Shenzhen Hepalink Reports Strong Profit Recovery in 2024 Annual Results
5M ago
9989
Shenzhen Hepalink to Approve Annual Results and Consider Dividend
PremiumCompany Announcements
Shenzhen Hepalink to Approve Annual Results and Consider Dividend
6M ago
9989
Shenzhen Hepalink’s Enoparin Gains Approval in Argentina, Boosting Global Expansion
PremiumCompany Announcements
Shenzhen Hepalink’s Enoparin Gains Approval in Argentina, Boosting Global Expansion
6M ago
9989
Shenzhen Hepalink Receives Approval for Clinical Trial of New Cancer Drug
PremiumCompany Announcements
Shenzhen Hepalink Receives Approval for Clinical Trial of New Cancer Drug
7M ago
9989
Shenzhen Hepalink Strengthens European Market Position with EMA GMP Certification
PremiumCompany Announcements
Shenzhen Hepalink Strengthens European Market Position with EMA GMP Certification
7M ago
9989
Shenzhen Hepalink Expects Strong Financial Turnaround in 2024
PremiumCompany AnnouncementsShenzhen Hepalink Expects Strong Financial Turnaround in 2024
8M ago
9989
Hepalink Partners with Yongtai for U.S. Gabapentin Market
Premium
Company Announcements
Hepalink Partners with Yongtai for U.S. Gabapentin Market
8M ago
9989
Shenzhen Hepalink Releases 2024 Q3 Financial Report
Premium
Company Announcements
Shenzhen Hepalink Releases 2024 Q3 Financial Report
10M ago
9989

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >